SCHEMBL953066

SCHEMBL953066

C=CCOC(=O)OCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.48
HPGD P15428 1/20 0.41
HCAR2 Q8TDS4 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
ALDH1A1 P00352 6/20 0.39
CYP3A4 P08684 2/20 0.38
MAPT P10636 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
ATM Q13315 1/20 0.34
LMNA P02545 1/20 0.34
GRM2 Q14416 1/20 0.34
GRM3 Q14832 1/20 0.34
HSD17B10 Q99714 1/20 0.33
ESR1 P03372 1/20 0.33
CHRM1 P11229 1/20 0.33
SLC6A2 P23975 1/20 0.33
KDR P35968 1/20 0.33
PLA2G2C Q5R387 1/20 0.33
MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18095147 1.00 TSHR (0.48) TSHRHPGDHCAR2TDP1ALDH1A1
SCHEMBL21233305 0.92 TSHR (0.44) TSHRHPGDHCAR2TDP1ALDH1A1
SCHEMBL7091016 0.92 TSHR (0.46) TSHRHPGDHCAR2TDP1ALDH1A1
SCHEMBL7260853 0.88 TSHR (0.44) TSHRHPGDHCAR2TDP1ALDH1A1
SCHEMBL7267486 0.88 TSHR (0.57) TSHRHPGDHCAR2TDP1ALDH1A1
SCHEMBL28139259 0.88 MEN1 (0.42) TSHRHPGDHCAR2TDP1ALDH1A1
SCHEMBL176184 0.86 CYP3A4 (0.43) TSHRHPGDTDP1ALDH1A1CYP3A4
SCHEMBL309590 0.86 TSHR (0.58) TSHRHPGDHCAR2ALDH1A1CYP3A4
SCHEMBL9245159 0.86 TSHR (0.58) TSHRHPGDHCAR2ALDH1A1CYP3A4
SCHEMBL28747016 0.84 TSHR (0.56) TSHRHPGDHCAR2ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119143923-A Multipolymer, preparation method thereof, polymer electrolyte and solid lithium ion battery 北京卫蓝新能源科技股份有限公司 2024-12-17 CN claimed
CN-114716923-B Photovoltaic packaging adhesive film 杭州福斯特应用材料股份有限公司 2024-01-05 CN claimed
CN-112838267-B Polymer-based electrolyte, preparation method thereof and solid-state battery 郑州宇通集团有限公司 2022-09-23 CN claimed
CN-114716923-A Photovoltaic packaging adhesive film 杭州福斯特应用材料股份有限公司 2022-07-08 CN claimed
US-7872135-B2 Method for introducing a 1,2-double bond into 3-oxo-4-azasteroid compounds SIEGFRIED LTD. (CH) 2011-01-18 US claimed
EP-1523490-B1 METHOD FOR INTRODUCING A 1,2 DOUBLE BOND INTO 3-OXO-4-AZASTEROID COMPOUNDS SIEGFRIED GENERICS INT AG (CH) 2009-12-23 EP claimed
EP-1648858-B1 METHOD FOR PRODUCTION OF ALPHA, BETA-UNSATURATED AMIDE COMPOUNDS SIEGFRIED GENERICS INT AG (CH) 2008-07-02 EP claimed
US-20060281949-A1 Method for production $g(a),$g(b)-unsaturated amide compounds SIEGFRIED GENERICS INTERNATIONAL AG (CH) 2006-12-14 US claimed
US-20060100434-A1 Method for introducing a 1,2-double bond into 3-oxo-4-azasteroid compounds SIEGFRIED LTD. (CH) 2006-05-11 US claimed
EP-1648858-A1 METHOD FOR PRODUCTION OF ALPHA, BETA-UNSATURATED AMIDE COMPOUNDS Siegfried Generics International AG (CH) 2006-04-26 EP claimed
EP-1523490-A1 METHOD FOR INTRODUCING A 1,2 DOUBLE BOND INTO 3-OXO-4-AZASTEROID COMPOUNDS Siegfried Generics International AG (CH) 2005-04-20 EP claimed
WO-2005007618-A1 METHOD FOR PRODUCTION OF $G(A),$G(B)-UNSATURATED AMIDE COMPOUNDS SIEGFRIED GENERICS INTERNATIONAL AG (CH) 2005-01-27 WO claimed
WO-2004007523-A1 METHOD FOR INTRODUCING A 1,2 DOUBLE BOND INTO 3-OXO-4-AZASTEROID COMPOUNDS SIEGFRIED GENERICS INTERNATIONAL AG (CH) 2004-01-22 WO claimed
CN-119812477-A Lithium secondary battery and nonaqueous electrolyte used therein 三菱化学株式会社 2025-04-11 CN disclosed
CN-119143923-A Multipolymer, preparation method thereof, polymer electrolyte and solid lithium ion battery 北京卫蓝新能源科技股份有限公司 2024-12-17 CN disclosed
CN-119133604-A Lithium secondary battery and nonaqueous electrolyte used therein 三菱化学株式会社 2024-12-13 CN disclosed
EP-0428343-B1 A process for producing an alpha,beta-unsaturated carbonyl compound NIPPON ZEON CO (JP) 1994-05-04 EP disclosed
US-5118863-A Process for producing an α,β-unsaturated carbonyl compound NIPPON ZEON CO., LTD. (JP) 1992-06-02 US disclosed
EP-0428343-A1 A process for producing an alpha,beta-unsaturated carbonyl compound NIPPON ZEON CO., LTD. (JP) 1991-05-22 EP disclosed
EP-0404497-A2 A process for producing an alpha,beta-unsaturated carbonyl compound NIPPON ZEON CO., LTD. (JP) 1990-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060100434-A1 Method for introducing a 1,2-double bond into 3-oxo-4-azasteroid compounds NR3C2, NR5A1, CYP11B1 TSHR 345/4885HPGD 361/4885HCAR2 206/4885
US-20060281949-A1 Method for production $g(a),$g(b)-unsaturated amide compounds GSTA2, GSTO1, GLB1 TSHR 3217/4885HPGD 151/4885HCAR2 1197/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.